Menstrual abnormalities and predisposition to pregnancy-related hypertensive disorders: A retrospective study

Gynecological Endocrinology

Volumn 26, Issue 6, 2010, Pages 445-450

  Fruscalzo, Arrigo ^a   Bertozzi, Serena ^b   Londero, Ambrogio P ^b   Biasioli, Anna ^b   Driul, Lorenza ^b   Kiesel, Ludwig ^a   Marchesoni, Diego ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

Endometrium; Polycystic ovary syndrome; Pregnancy

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DYSMENORRHEA; FEMALE; HUMAN; HYPERMENORRHEA; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; MENSTRUATION DISORDER; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL;

COMORBIDITY; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; MENSTRUAL CYCLE; MENSTRUATION DISTURBANCES; PREDICTIVE VALUE OF TESTS; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 77952211475     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513591003632092     Document Type: Article

References (40)

1. Roberts JM, Pearson G, Cutler J, Lindheimer M, on Research on Hypertension During Pregnancy NHLBIWG. Summary of the NHLBI Working Group on research on hypertension during pregnancy. Hypertension 2003;41:437-445. (Pubitemid 36314613)
2. Baumwell S, Karumanchi SA. Pre-eclampsia: clinical manifestations and molecular mechanisms. Nephron Clin Pract 2007;106:c72-c81.
3. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785-799.
4. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592-1594.
5. Webster RP, Roberts VHJ, Myatt L. Protein nitration in placenta - functional significance. Placenta 2008;29:985-994.
6. Sandrim VC, Palei ACT, Metzger IF, Gomes VA, Cavalli RC, Tanus-Santos JE. Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia. Hypertension 2008;52:402-407.
7. Atkinson KR, Blumenstein M, Black MA, Wu SH, Kasabov N, Taylor RS, Cooper GJS, North RA, Consortium, SCOPE. An altered pattern of circulating apolipoprotein E3 isoforms is implicated in preeclampsia. J Lipid Res 2009;50:71-80.
8. Alemán I, Alex R, Ramírez M, Hung A, Ramírez C. Endothelial and inducible nitric oxide synthase expression in Venezuelan patients with pre-eclampsia. Invest Clin 2008;49: 321-330.
9. Sandrim VC, Palei AC, Cavalli RC, Araújo FM, Ramos ES, Duarte G, et al. eNOS haplotypes associated with gestational hypertension or preeclampsia. Pharmacogenomics 2008;9: 1467-1473.
10. Hocher B, Chen YP, Hügle S, Repey J, Krause K, Slowinski T, Godes M, Schaeffeler E, Guthmann F, Wauer R, et al. Impact of maternal endothelial nitric oxide synthase gene polymorphisms on blood pressure, protein excretion and fetal outcome in pregnancy. J Hum Hypertens 2008;22:641-647.
11. Kim YJ, Park BH, Park H, Jung SC, Pang MG, Ryu HM, Lee KS, Eom SM, Park HY. No association of the genetic polymorphisms of endothelial nitric oxide synthase, dimethylarginine dimethylaminohydrolase, and vascular endothelial growth factor with preeclampsia in Korean populations. Twin Res Hum Genet 2008;11:77-83.
12. Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M, Murphy SR, Granger JP. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol 2008;294:H541-H550. (Pubitemid 351253261)
13. Escudero C, Sobrevia L. A hypothesis for preeclampsia: adenosine and inducible nitric oxide synthase in human placental microvascular endothelium. Placenta 2008;29:469-483.
14. Chen D, Wang H, Huang H, Dong M. Vascular endothelial growth factor attenuates Nomega-nitro-L-arginine methyl ester-induced preeclampsia-like manifestations in rats. Clin Exp Hypertens 2008;30:606-615.
15. Smith OPM, Jabbour HN, Critchley HOD. Cyclooxygenase enzyme expression and E series prostaglandin receptor signalling are enhanced in heavy menstruation. Hum Reprod 2007;22:1450-1456.
16. Harel Z. Dysmenorrhea in adolescents and young adults: from pathophysiology to pharmacological treatments and management strategies. Expert Opin Pharmacother 2008;9: 2661-2672.
17. Lethaby A, Augood C, Duckitt K, Farquhar C. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev 2007;4:CD000400.
18. Dawood MY, Khan-Dawood FS. Differential suppression of menstrual fluid prostaglandin F2a, prostaglandin E2, 6-keto prostaglandin F1a and thromboxane B2 by suprofen in women with primary dysmenorrhea. Prostaglandins Other Lipid Mediat 2007;83:146-153.
19. Eby GA. Zinc treatment prevents dysmenorrhea. Med Hypotheses 2007;69:297-301.
20. Dikensoy E, Balat O, Pençe S, Balat A, Cekmen M, Yurekli M. Malondialdehyde, nitric oxide and adrenomedullin levels in patients with primary dysmenorrhea. J Obstet Gynaecol Res 2008;34:1049-1053.
21. Manau D, Balasch J, Jiménez W, Fábregues F, Casamitjana R, Creus M, Arroyo V, Vanrell JA. Adrenomedullin and nitric oxide in menstrual and in vitro fertilization cycles. Relationship to estradiol. Acta Obstet Gynecol Scand 1999;78: 626-631.
22. Tschugguel W, Schneeberger C, Unfried G, Bráutigam G, Stonek F, Wieser F, Vytiska-Binstorfer E, Czerwenka K, Weninger W, Kaider A, et al. Elevation of inducible nitric oxide synthase activity in human endometrium during menstruation. Biol Reprod 1999;60:297-304. (Pubitemid 29063869)
23. Shaamash AH, Zakhari MM. Increased serum levels of nitric oxide metabolites among users of levonorgestrel-releasing implants corrected a possible role in progestin-induced bleeding. Hum Reprod 2005;20:302-306.
24. Johnson S. The multifaceted and widespread pathology of magnesium deficiency. Med Hypotheses 2001;56:163-170.
25. Hickey M, Fraser IS. Clinical implications of disturbances of uterine vascular morphology and function. Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:937-951.
26. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Preeclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;335:974.
27. Kajantie E, Eriksson JG, Osmond C, Thornburg K, Barker DJP. Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke 2009;40:1176-1180.
28. Forest JC, Girouard J, MasséJ, Moutquin JM, Kharfi A, Ness RB, Roberts JM, Giguère Y. Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet Gynecol 2005;105:1373-1380.
29. Tfayli H, Arslanian S. Menstrual health and the metabolic syndrome in adolescents. Ann N Y Acad Sci 2008;1135: 85-94.
30. Giallauria F, Orio F, Palomba S, Lombardi G, Colao A, Vigorito C. Cardiovascular risk in women with polycystic ovary syndrome. J Cardiovasc Med (Hagerstown). 2008;9: 987-992.
31. Brown MA, Lindheimer MD, De Swiet M, Assche AV, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX-XIV.
32. Boomsma CM, Fauser BCJM, Macklon NS. Pregnancy complications in women with polycystic ovary syndrome. Semin Reprod Med 2008;26:72-84.
33. Consensus Workshop Group TRESP. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19: 41-47.
34. Hu S, Leonard A, Seifalian A, Hardiman P. Vascular dysfunction during pregnancy in women with polycystic ovary syndrome. Hum Reprod 2007;22:1532-1539. (Pubitemid 47055139)
35. Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol 2006;108:428-441.
36. Leyendecker G. Redefining endometriosis: endometriosis is an entity with extreme pleiomorphism. Hum Reprod 2000;15: 4-7.
37. Berkley KJ. A life of pelvic pain. Physiol Behav 2005;86: 272-280.
38. Brinkert W, Dimcevski G, Arendt-Nielsen L, Drewes AM, Wilder-Smith OHG. Dysmenorrhoea is associated with hypersensitivity in the sigmoid colon and rectum. Pain 2007; 132(Suppl 1)S46-S51.
39. Kaaja RJ, Pöyhönen-Alho MK. Insulin resistance and sympathetic overactivity in women. J Hypertens 2006;24:131-141.
40. Brook RD, Julius S. Autonomic imbalance, hypertension, and cardiovascular risk. Am J Hypertens 2000;13(6 Pt 2): 112S-122S.